AC

AIGH Capital Management

North America, Maryland, United States, Baltimore

Description

AIGH Capital Management is a private equity firm

Investor Profile

AIGH Capital Management has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 75% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Undisclosed rounds (top funding stages).
  • Majority of deals are located in United States, Israel.
  • Strong thematic focus on Medical, Biotechnology, Health Care.
  • Led 1 rounds in the past year.

Stage Focus

  • Post Ipo Equity (75%)
  • Undisclosed (25%)

Country Focus

  • United States (75%)
  • Israel (25%)

Industry Focus

  • Medical
  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Dental
  • Product Design
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AIGH Capital Management frequently co-invest with?

Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 1
Second Line
North America, Louisiana, United States, New Orleans
Co-Investments: 1
Rosalind Capital Partners
North America, Ontario, Canada, Toronto
Co-Investments: 1
AP
North America, California, United States, Belmont
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by AIGH Capital Management?

Quoin Pharmaceuticals

Ashburn, Virginia, United States

Quoin Pharmaceuticals is into developing products which address major unmet medical needs.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityOct 10, 2025
Amount Raised: $104,500,000
Biofrontera

Woburn, Massachusetts, United States

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityJun 30, 2025
Amount Raised: $8,500,000
Plus Therapeutics

Austin, Texas, United States

Plus Therapeutics is a clinical-stage pharmaceutical company that develops targeted therapies to treat cancer and other serious diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Post Ipo EquityMay 6, 2024
Amount Raised: $6,500,000
Cellectar Biosciences

Madison, Wisconsin, United States

Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.

BiotechnologyMedical DeviceTherapeutics
Post Ipo EquitySep 5, 2023
Amount Raised: $103,000,000
Dror Ortho-Design

Jerusalem, Yerushalayim, Israel

Dror Ortho-Design develops an innovative AI-driven platform for painless and minimally invasive smile correction.

DentalHealth CareMedicalMedical DeviceProduct Design
UndisclosedJul 6, 2023
Amount Raised: $5,500,000